Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

Table 14 Difference in means between treatment and control groups for BMI at final follow-up

Author	Sample size (treatment group vs. control group)	Difference	95% CI
Caraccio et al. [58]	49 (24 vs. 25)	1.30 kg/m²*	− 0.33 to 2.93
Caraccio et al. [59]	23 (12 vs. 11)	− 0.40 kg/m²*	− 2.52 to 1.72
Duman et al. [60]	39 (20 vs. 19)	− 0.70 kg/m²*	− 2.91 to 1.51
Iqbal et al. [62]	64 (32 vs. 32)	1.40 kg/m²*	− 1.06 to 3.86
Liu et al. [64]	119 (60 vs. 59)	− 0.10 kg/m²**	− 0.51 to 0.31
Monzani et al. [67]	20 (10 vs. 10)	0.00 kg/m²*	− 3.22 to 3.22
Monzani et al. [68]	45 (23 vs. 22)	− 1.20 kg/m²*	− 3.34 to 0.94
Nagasaki et al. [69]	95 (48 vs. 47)	− 0.30 kg/m²**	− 1.26 to 0.66
Stott et al. [73]	638 (318 vs. 320)	0.0 kg/m²*	− 0.02 to 0.02
Teixeira et al. [74, 75]	26 (11 vs. 15)	2.90 kg/m²*	0.38–5.42
Yazici et al. [76]	45 (23 vs. 22)	− 0.20 kg/m²*	− 2.10 to 1.70

*Value is the difference in mean scores at final follow-up between treatment and control groups
**Value is the difference in mean variation scores from baseline to follow-up between treatment and control group